Picture of Cencora logo

COR Cencora Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapNeutral

Annual income statement for Cencora, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

2019
September 30th
2020
September 30th
2021
September 30th
2022
September 30th
2023
September 30th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue179,589189,894213,989238,587262,173
Cost of Revenue
Gross Profit4,9925,1836,7748,3358,807
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses178,477195,051211,635236,176259,792
Operating Profit1,112-5,1582,3542,4112,381
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes967-5,2942,2222,1832,161
Provision for Income Taxes
Net Income After Taxes817-3,4001,5451,6671,733
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income855-3,4091,5401,6991,745
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income855-3,4091,5401,6991,745
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS6.876.158.469.429.13
Dividends per Share